bpc 157 human clinical trial gastrointestinal Stable Gastric Pentadecapeptide as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System BPC-157 + TB-500 Blend Explained
Description
Yes, our IV drip treatments can be customised to meet individual goals
PubMed 6.Sikiric P et al
A 10 mg BPC-157 vial reconstituted with 5 mL of bacteriostatic water yields a 2 mg/mL concentration identical to the standard 5 mg / 2.5 mL preparation, so the same mL values apply: 250 g = 0.125 mL, 500 g = 0.25 mL
The procedure is quick and performed by our highly qualified providers to ensure your safety and the most comfortable treatment experience possible
